EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu